EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu